EU đặt mua 220.000 liệu trình điều trị COVID-19 của GlaxoSmithKline
Ngày 28/7, Liên minh châu Âu (EU) cho biết đã ký một thỏa thuận với công ty dược phẩm GlaxoSmithKline của Anh về việc cung cấp lên đến 220.000 liệu trình thuốc Sotrovimab điều trị bệnh nhân COVID-19 bằng kháng thể đơn dòng mà hãng này đang phát triển. GlaxoSmithKline cùng ngày cũng đã xác nhận thỏa thuận này.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu